EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu